EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu